Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

BA US Equity

Boeing CoIndustrials · Aircraft · CIK 12927 · FY ends Dec 31
$223.06
-2.89 (-1.28%)
USD · as of 2026-08-18 · marketstack
2 registered studies · 0 active

Studies where BA is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.

2 interventional

Held by 22 tracked-famous managers (VIKING GLOBAL INVESTORS LP, AQR CAPITAL MANAGEMENT LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, PRIMECAP MANAGEMENT CO/CA/, CITADEL ADVISORS LLC, +17 more) · FINRA short interest 2.4 days to cover (settled 2026-07-31) · government filings 180d: 2 congress / 5 executive

StudyPhaseStatusInterventionsConditionsEnrollmentPrimary completionUpdated
Effects of Mild Hypobaric Hypoxia on Oxygen Saturation During SleepNCT00659009SpO2Randomized · Double-masked · Basic scienceNot applicableCompletedOther: Reduced barometric pressure, Sea level equivalent barometric pressure, Reduced barometric pressureSleep-related Respiratory Disturbance16Mar 2009actual2012-08-15
Effects of Aircraft Cabin Altitude on Passenger Comfort and DiscomfortNCT00326703ESQ IV factor scores measured at 2 hour intervalsRandomized · Single-maskedNot applicableCompletedProcedure: Hypobaric hypoxiaAcute Mountain Sickness5002006-10-17

Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.

Source: ClinicalTrials.gov, retrieved 2026-08-19